Fresh Tracks Therapeutics Inc (OTCPK:FRTX)
$ 0.74 -0.005 (-0.67%) Market Cap: 4.45 Mil Enterprise Value: -4.51 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 52/100

Q1 2020 Brickell Biotech Inc Earnings Call Transcript

May 13, 2020 / 08:30PM GMT
Release Date Price: $63.45 (+13.25%)
Operator

Welcome, everyone, to the Brickell Biotech First Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the call over to Patty Bank, Managing Director, Westwicke Partners.

Patricia L. Bank
Westwicke Partners, LLC - MD

Thank you. Good afternoon, everyone. Joining me on today's call are Brickell's Chief Executive Officer, Rob Brown; Chief Financial Officer, Mike Carruthers; Chief R&D Officer, Deepak Chadha; Co-Founder and Chief Operating Officer, Andy Sklawer; Chief Business Officer, Adam Levy; and General Counsel, Chief Compliance Officer, David Mcavoy.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ materially. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We do not undertake any obligation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot